top of page
News
Senate begins quest to demystify PBMs' practices as it mulls legislation
The Senate Commerce Committee today held a hearing in which members on both sides of the aisle raised questions about the practices of...
Feb 17, 2023
Chairman of the Board Response to U.S. Senators’ Efforts to Hold PBMs Accountable
Doug Dority, Chairman of the Board of the PBM Accountability Project penned a letter to Senators Maria Cantwell and Chuck Grassley in...
Feb 16, 2023
Senators question why PBMs 'even exist' in heated hearing amid push for reform
Senators pilloried the lack of transparency from pharmacy benefit managers during a hearing Thursday, as lawmakers hope to pass reforms...
Feb 16, 2023
Tough day for PBMs
It's never pleasant for your industry when senators are publicly musing at a hearing about whether your companies should exist, but...
Feb 16, 2023
How 3 companies came to dominate the PBM market
When you think of industries dominated by a few powerful players (*cough* tech *cough*), the pharmacy benefit manager (PBM) industry...
Feb 15, 2023
Mark Cuban Assails PBMs at AAM meeting
Mark Cuban made scathing, profanity-laced remarks about pharmacy benefit managers (PBMs) and heaped praised on drug manufacturers...
Feb 14, 2023
Health care giant Centene settles with another state, California
Medicaid managed-care giant Centene has agreed to pay California $215 million to settle a drug-pricing scandal related to one that was...
Feb 14, 2023
PBM Accountability Project Chairman of the Board Response to State of the Union address
Doug Dority, Chairman of the Board of the PBM Accountability Project penned a letter to members of the Biden Administration in response...
Feb 9, 2023
Biden’s SOTU Targets Drug Companies, But Misses Opportunity To Challenge Health Insurers And PBMs
President Biden’s State of the Union Address hammered home the point that drug prices must come down. He reminded viewers that he and his...
Feb 8, 2023
States, not Federal Government, Are Moving to Tighten Regulation of PBMs
The politics and policies of high drug prices have been swirling around for years. But recently, attention has shifted to PBMs, which...
Feb 7, 2023
Need a new drug? You may be asked to ‘fail’ an old drug first
Many patients seeking better drug treatments are being rejected by their insurance companies. The reason: Patients must first “fail” at...
Feb 7, 2023
Bipartisan Policy Center Brief: High Drug Prices: Are PBMs the Right Target?
Pharmacy benefit managers (PBMs) may be Congress’ next target for high prescription drug prices. There is evidence that PBMs may be...
Feb 2, 2023
Centene to pay $66.5 million in Indiana Medicaid drug pricing settlement
Health care services company Centene Corp. will pay Indiana nearly $66.5 million to resolve allegations that it overcharged the state’s...
Feb 1, 2023
Corporate bad actors make billions from abusing program designed to help low-income patients | Guest
Large hospital systems and pharmacy benefit managers have been taking advantage of a federal program for far too long, netting billions...
Jan 21, 2023
Why Now Is the Time for Health Plans to Take Control of Pharmacy Benefits
Health plans today must consider what they want out of their pharmacy benefits and how to achieve something better for their members. And...
Jan 20, 2023
It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs
Although per capita patient out-of-pocket (OOP) spending on prescription medications has dropped, averages are deceiving. In the U.S., a...
Jan 15, 2023
Lawmakers are readying fresh attacks on pharmacy middlemen
As key lawmakers gear up for the new Congress, there’s at least one industry that will be caught in the crosshairs: pharmacy benefit...
Jan 14, 2023
With the FTC’s more expansive approach to antitrust, PBMs are in the crosshairs
WASHINGTON — The Democrats leading the Federal Trade Commission are hoping to expand the agency’s authority to crack down on unfair...
Jan 13, 2023
Congress Can Stop Pharmacy Benefit Managers from Manipulating Patients
Millions of Americans rely on prescription medications to manage their illnesses. According to polling conducted by the Kaiser Family...
Jan 6, 2023
The PBM defense playbook
Congress isn't exactly off to a running start. But when the House gets its act together, one of the top potential areas for bipartisan...
Jan 5, 2023
Drug Pricing Oversight to Get Prime Focus Under New Congress
Overseeing Medicare’s new authority to negotiate prices of the country’s highest-spending drugs is among the top priorities for lawmakers...
Jan 3, 2023
Opinion: Fixing price instability can improve access to affordable prescription drugs
The high cost of prescription drugs is a very real problem in the United States. The average American spends approximately $1,300 per...
Dec 15, 2022
Commentary: Don't let insurers just pocket prescription co-pay aid
Family physicians care for patients young and old throughout their lives. It is often our duty to tell a patient that he or she has a...
Dec 15, 2022
New report on Oregon pharmacy reimbursement abuses reaffirms need for industry reforms
A recent report out of Oregon found “significant disparities in reimbursement” between retail pharmacies in the study and all other...
Dec 1, 2022
bottom of page
